Sulfasalazine is an old Sulfasalazine, a disease-modifying antirheumatic drug (DMARD), has a well established role in the treatment of patients with rheumatoid arthritis, spondyloarthritis, and inflammatory bowel disease—diseases in which therapeutic benefit may primarily derive from the drug's inhibitory effect on tumour necrosis factor (TNF) and prostaglandin
The mode of action of sulfasalazine is unclear and is suggested as being: anti-inflammatory, immunosuppressive and bacteriostatic
It is taken by mouth or can be administered rectally
Both of these can cause inflammation in the large intestine, leading to problems such as tummy (abdominal) pain and diarrhoea
Sulfasalazine enteric-coated tablets are used to treat adults and children with rheumatoid arthritis in patients who have not been helped by or who Pharmacodynamics
Changes in the amount of urine
Postmarketing side effects of sulfasalazine reported include: Blood dyscrasias: Pseudomononucleosis
Children 2 to 5 years of age—Dose must be determined by your doctor
0
This study aims to assess the efficacy of SASP as a supplementary therapy for pre-XDR-TB